manitmad555

AARTIIND SWING TREND

Long
NSE:AARTIIND   AARTI IND LTD
AARTI Industries Ltd. is a holding company, which engages in the development and manufacture of specialty chemicals, pharmaceuticals, and home and personal care intermediates. It operates through the following segments: Specialty Chemicals and Pharmaceuticals. The Specialty Chemicals segment offers benzene, sulphur, and toluene product chains. The Pharmaceuticals segment focuses on active pharmaceutical ingredients, custom synthesis, and contract research. The company was founded by Chandrakant Vallabhaji Gogri and Shantilal Tejshi Shah on September 28, 1984 and is headquartered in Mumbai, India.
Aarti Industries Limited manufactures and sells specialty chemicals and pharmaceuticals in India. It offers di chloro benzene, nitro chloro and nitro benzene, nitro toluenes, sulphur, and other organic and inorganic products that are used in the manufacture of intermediates with applications in agrochemicals, pharmaceuticals, polymer additives, fuel additives, FMCG, dyes, pigments, paints, printing inks, rubber chemicals, resins, and other speciality chemical applications. The company also provides active pharmaceutical ingredients, which have applications in anti-hypertensive, anti asthamatic, anti-cancer, anti thalassaemic, analgesic, ophthalmologic, and calcimimetics; central nervous system agents; and skin care and decongestant products. In addition, it offers intermediates; and xanthine derivatives, such as caffeine anhydrous, theophylline, aminophylline, acephylline piperazine, choline theophylline, doxofylline, DMAU, and theobromine derivatives, as well as contract manufacturing and research services. The company also exports its products to approximately 60 countries in North America, Europe, China, Japan, and internationally. Aarti Industries Limited was incorporated in 1984 and is headquartered in Mumbai, India.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.